These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9132593)

  • 1. Valvular heart disease and systemic lupus erythematosus.
    McCarthy GM; McCarty DJ
    N Engl J Med; 1997 May; 336(18):1324; author reply 1324-5. PubMed ID: 9132593
    [No Abstract]   [Full Text] [Related]  

  • 2. Valvular heart disease and systemic lupus erythematosus.
    Piette JC; Amoura Z; Papo T
    N Engl J Med; 1997 May; 336(18):1324; author reply 1324-5. PubMed ID: 9132594
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies.
    Gabrielli F; Alcini E; Di Prima MA; Mazzacurati G; Masala C
    Int J Cardiol; 1995 Sep; 51(2):117-26. PubMed ID: 8522406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valvular lesions in patients with systemic lupus erythematosus and antiphospholipid syndrome: an old disease but a persistent challenge.
    Ferreira E; Bettencourt PM; Moura LM
    Rev Port Cardiol; 2012 Apr; 31(4):295-9. PubMed ID: 22386150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiological aspects of the antiphospholipid syndrome. Part I. Valvular lesions in the primary and secondary antiphospholipid syndrome and systemic lupus erythematosus].
    Reshetniak TM; Kotel'nikova GP; Fomicheva OA; Kliukvina NG; Karpov IuA; Alexandrova EN; Alekberova ZS; Sergakova LM; Nasonova VA; Nasonov EL
    Kardiologiia; 2002; 42(8):38-43. PubMed ID: 12494093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies.
    Roldan CA; Shively BK; Lau CC; Gurule FT; Smith EA; Crawford MH
    J Am Coll Cardiol; 1992 Nov; 20(5):1127-34. PubMed ID: 1341885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valvular and coronary heart disease in systemic inflammatory diseases: Systemic Disorders in heart disease.
    Roldan CA
    Heart; 2008 Aug; 94(8):1089-101. PubMed ID: 18625800
    [No Abstract]   [Full Text] [Related]  

  • 8. [Association of antiphospholipid antibodies with valvular heart disease in patients with systemic lupus erythematosus].
    Hosaka K; Okada J; Ogiwara A; Kobayashi A; Kondo H
    Ryumachi; 1994 Feb; 34(1):22-9. PubMed ID: 8146724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibodies and valve disease in patients with systemic lupus erythematosus.
    Khamashta MA; Hughes GR
    J Am Coll Cardiol; 1993 Oct; 22(4):1269-70. PubMed ID: 8409067
    [No Abstract]   [Full Text] [Related]  

  • 10. Valvular heart disease in systemic lupus erythematosus: another symptom of the disease or a hallmark of secondary antiphospholipid syndrome?
    Musial J
    Eur Heart J; 1997 Nov; 18(11):1836-7. PubMed ID: 9402462
    [No Abstract]   [Full Text] [Related]  

  • 11. Valvulitis requiring triple valve surgery as an initial presentation of systemic lupus erythematosus.
    Einav E; Gitig A; Marinescu LM; Tanaka KE; Spevack DM
    J Am Soc Echocardiogr; 2007 Nov; 20(11):1315.e1-3. PubMed ID: 17600680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Involvement of cardiac valves in antiphospholipid syndrome].
    Sergakova LM; Fomicheva OA; Vil'chinskaia MI; Alekberova ZS; Aleksandrova EN; Karpov IA; Nasonov EL; At'kov OI
    Klin Med (Mosk); 1996; 74(9):39-42. PubMed ID: 9121087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid antibodies and the risk of thromboembolic events in valvular heart disease.
    Bulckaen HG; Puisieux FL; Bulckaen ED; Di Pompeo C; Bouillanne OM; Watel AA; Fauchais AL; De Groote P; Millaire A
    Mayo Clin Proc; 2003 Mar; 78(3):294-8. PubMed ID: 12630582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment.
    Nesher G; Ilany J; Rosenmann D; Abraham AS
    Semin Arthritis Rheum; 1997 Aug; 27(1):27-35. PubMed ID: 9287387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter aortic valve replacement for advanced valvular disease in active SLE and APS.
    Bert JS; Abdullah M; Dahle TG; Gertner E
    Lupus; 2013 Sep; 22(10):1046-9. PubMed ID: 23884983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart valve disease in systemic lupus erythematosus. Role of antiphospholipid antibodies.
    Meyer O; Golstein M; Nicaise P; Labarre C; Kahn MF
    Clin Rev Allergy Immunol; 1995; 13(1):49-56. PubMed ID: 7648348
    [No Abstract]   [Full Text] [Related]  

  • 17. Isolated tricuspid valve Libman-Sacks endocarditis in a patient with antiphospholipid antibody syndrome.
    Mahajan K; Negi P; Merwaha R; Sharma M
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28830895
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiphospholipid syndrome nephropathy in antiphospholipid antibody-positive patients with systemic lupus erythematosus: comment on the article by Tektonidou et al.
    Korkmaz C
    Arthritis Rheum; 2005 Mar; 52(3):988-9; author reply 989-90. PubMed ID: 15751054
    [No Abstract]   [Full Text] [Related]  

  • 19. Valvular heart disease and systemic lupus erythematosus: therapeutic implications.
    Fluture A; Chaudhari S; Frishman WH
    Heart Dis; 2003; 5(5):349-53. PubMed ID: 14503933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid antibodies and the antiphospholipid syndrome. Clinical relevance in neuropsychiatric systemic lupus erythematosus.
    Alarcón-Segovia D; Estañol B; García-Ramos G; Villa AR
    Ann N Y Acad Sci; 1997 Aug; 823():279-88. PubMed ID: 9292055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.